Overview
Acropectorovertebral dysplasia, also known as F syndrome or Acropectorovertebral syndrome, is a rare congenital malformation syndrome primarily affecting the skeletal system. The condition was first described by Dundar et al. and is characterized by a distinctive combination of limb, chest, and spinal anomalies. Key features include fusion of the fingers and toes (syndactyly), particularly involving a characteristic fusion pattern in the hands that may resemble a mitten-like appearance, along with preaxial polydactyly (extra digits on the thumb side). Chest wall abnormalities, including pectus carinatum or other sternal malformations, and vertebral segmentation defects affecting the spine are also hallmark features of the condition. The skeletal abnormalities are present from birth and may vary in severity even among affected members of the same family. Additional features can include carpal and tarsal bone fusions, synostosis (abnormal bony fusion) of various bones, and spina bifida occulta. The upper limbs tend to be more severely affected than the lower limbs. Intelligence and cognitive development are typically normal in affected individuals. There is no specific cure or targeted therapy for acropectorovertebral dysplasia. Management is primarily supportive and symptomatic, focusing on orthopedic interventions. Surgical correction of syndactyly and polydactyly may be performed to improve hand function and appearance. Spinal abnormalities may require monitoring and, in some cases, orthopedic management to prevent complications such as scoliosis. Genetic counseling is recommended for affected families given the hereditary nature of the condition.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
10 eventsCambridge Health Alliance — NA
Medical University of Vienna
Medical University of South Carolina — NA
University of California, Davis — EARLY_PHASE1
Gulhane Training and Research Hospital
National Center for AIDS/STD Control and Prevention, China CDC — PHASE4
McGill University Health Centre/Research Institute of the McGill University Health Centre — PHASE4
Pontificia Universidad Catolica de Chile
Centre Hospitalier Universitaire de Saint Etienne
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Acropectorovertebral dysplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Acropectorovertebral dysplasia at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Acropectorovertebral dysplasia.
Community
No community posts yet. Be the first to share your experience with Acropectorovertebral dysplasia.
Start the conversation →Latest news about Acropectorovertebral dysplasia
Disease timeline:
New recruiting trial: Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region
A new clinical trial is recruiting patients for Acropectorovertebral dysplasia
New recruiting trial: Imaging Immune Activation in HIV by PET-MR
A new clinical trial is recruiting patients for Acropectorovertebral dysplasia
New recruiting trial: Imaging Immune Activation in COVID-19
A new clinical trial is recruiting patients for Acropectorovertebral dysplasia
New recruiting trial: Impact of Frailty and ICU-AW on Post-ICU Fatigue Self-reported
A new clinical trial is recruiting patients for Acropectorovertebral dysplasia
New recruiting trial: Translation and Validation of the French mPCOSQ (mPCOSQ-F).
A new clinical trial is recruiting patients for Acropectorovertebral dysplasia
New recruiting trial: Incidence and Factors Associated to the Development of PICS-F Among ICU Relatives: A Longitudinal Exploratory Study
A new clinical trial is recruiting patients for Acropectorovertebral dysplasia
New recruiting trial: Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot
A new clinical trial is recruiting patients for Acropectorovertebral dysplasia
New recruiting trial: Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
A new clinical trial is recruiting patients for Acropectorovertebral dysplasia
New recruiting trial: Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)
A new clinical trial is recruiting patients for Acropectorovertebral dysplasia
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Acropectorovertebral dysplasia
What is Acropectorovertebral dysplasia?
Acropectorovertebral dysplasia, also known as F syndrome or Acropectorovertebral syndrome, is a rare congenital malformation syndrome primarily affecting the skeletal system. The condition was first described by Dundar et al. and is characterized by a distinctive combination of limb, chest, and spinal anomalies. Key features include fusion of the fingers and toes (syndactyly), particularly involving a characteristic fusion pattern in the hands that may resemble a mitten-like appearance, along with preaxial polydactyly (extra digits on the thumb side). Chest wall abnormalities, including pectus
How is Acropectorovertebral dysplasia inherited?
Acropectorovertebral dysplasia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Acropectorovertebral dysplasia typically begin?
Typical onset of Acropectorovertebral dysplasia is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Acropectorovertebral dysplasia?
3 specialists and care centers treating Acropectorovertebral dysplasia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.